2014, Number 1
<< Back Next >>
Ann Hepatol 2014; 13 (1)
Autoimmune liver disorders and small-vessel vasculitis: four case reports and review of the literature
Tovoli F, Vannini A, Fusconi M, Frisoni M, Zauli D
Language: English
References: 29
Page: 136-141
PDF size: 93.43 Kb.
ABSTRACT
Autoimmune liver diseases (AILD) are a group of immunologically induced hepatic disorders that can lead to
liver cirrhosis and end-stage liver disease. Extra-hepatic involvement and association with rheumatic diseases
(such as Sjögren’s syndrome, systemic sclerosis and rheumatoid arthritis) are well known, whereas
the coexistence of AILD with small-vessel vasculitis in the same patients have been only occasionally reported.
In the present paper we report four such cases and an extensive review of the literature. Clinical
features of autoimmune-liver diseases associated with small-vessel vasculitis are discussed, as well as possible
common pathogenic pathways including HLA genomics, costimulatory molecules and autoantibodies. In
conclusion, knowledge about this association can help physicians in recognising and treating an aggressive
disease which could otherwise result in severe and multiple organ damage, compromising the overall prognosis
and the indication to liver transplantation.
REFERENCES
Kumagi T, Alswat K, Hirschfield GM, Heathcote J. New insights into autoimmune liver diseases. Hepatol Res 2008; 38: 745-61.
Granito A, Muratori L, Pappas G, Muratori P, Ferri S, Cassani F, Lenzi M, et al. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients. Aliment Pharmacol Ther 2005; 21: 1273-7.
Marasini B, Gagetta M, Rossi V, Ferrari P. Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients. Ann Rheum Dis 2001; 60: 1046-9.
Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiødt M, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012; 64: 475-87.
Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology 2009; 50: 291-308.
Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088-93.
Amezcua-Guerra LM, Prieto P, Bojalil R, Pineda C, Amigo MC. Microscopic polyangiitis associated with primary biliary cirrhosis: a causal or casual association? J Rheumatol 2006; 33: 2351-3.
Iannone F, Falappone P, Pannarale G, Gentile A, Grattagliano V, Covelli M, Lapadula G. Microscopic polyangiitis associated with primary biliary cirrhosis. J Rheumatol 2003; 30: 2710-2.
Yoshimoto T, Kagotani K, Hirao F, Tamai M. Wegener’s granulomatosis in a woman with asymptomatic primary biliary cirrhosis. Nihon Kyobu Shikkan Gakkai Zasshi 1989; 27: 1545-50.
Conn DL, Dickson ER, Carpenter HA. The association of Churg-Strauss vasculitis with temporal artery involvement, primary biliary cirrhosis, and polychondritis in a single patient. J Rheumatol 1982; 9: 744-8.
Sinico RA, Sabadini E, Maresca AM. Mesalazine-induced Churg-Strauss syndrome in a patient with Crohn’s disease and sclerosing cholangitis. Clin Exp Rheumatol 2006; 24(2 Suppl. 41): S104.
Yüksel I, Dagli U, Ataseven H, Sahin B. Sclerosing cholangitis associated with Wegener’s granulomatosis. J Gastroenterol Hepatol 2006; 21: 1765-6.
Allende DS, Booth CN. Wegener’s granulomatosis of the breast: a rare entity with daily clinical relevance. Ann Diagn Pathol 2009; 13: 351-7.
Imai H, Nakamoto Y, Nakajima Y, Sugawara T, Miura AB. Allergic granulomatosis and angiitis (Churg-Strauss syndrome) presenting as acute acalculous cholecystitis. J Rheumatol 1990; 17: 247-9.
Pagnoux C. Churg-Strauss syndrome: evolving concepts. Discov Med 2010; 9: 243-52.
Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, Ferri S, et al. Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim-like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment Pharmacol Ther 2006; 24: 1575-83.
Moloney MM, Thomson LJ, Strettell MJ, Williams R, Donaldson PT. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology 1998; 28: 660-2.
Strettell MD, Thomson LJ, Donaldson PT, Bunce M, O’Neill CM, Williams R. HLA-C genes and susceptibility to type 1 autoimmune hepatitis. Hepatology 1997; 26: 1023-6.
Stassen PM, Cohen-Tervaert JW, Lems SP, Hepkema BG, Kallenberg CG, Stegeman CA. HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener’s granulomatosis. Rheumatology (Oxford) 2009; 48: 622-5.
Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, Almasio P, et al; Italian PBC Genetic Study Group. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008; 48: 1906-12.
Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Lazaridis KN. Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene. Gastroenterology 2008; 135: 1200-6.
Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000; 31: 49-53.
Donaldson PT, Norris S. Immunogenetics in PSC. Best Pract Res Clin Gastroenterol 2001; 15: 611-27.
Giscombe R, Wang X, Huang D, Lefvert AK. Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener’s granulomatosis. J Rheumatol 2002; 29: 950-3.
Steiner K, Moosig F, Csernok E, Selleng K, Gross WL, Fleischer B, Brocker BM. Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener’s granulomatosis. Clin Exp Immunol 2001; 126: 143-50.
Kallenberg CG, Mulder AH, Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992; 93: 675-82.
Terjung B, Söhne J, Lechtenberg B, Gottwein J, Muennich M, Herzog V, Mahler M, et al. p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ. Gut 2010; 59: 808-16.